Cargando…
Controlled Trial Data Casts Doubt on the Supposed Benefit of Lung Metastasectomy. Comment on Chandra et al. The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis. Cancers 2021, 13, 6206
Autores principales: | Macbeth, Fergus, Treasure, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454810/ https://www.ncbi.nlm.nih.gov/pubmed/36077771 http://dx.doi.org/10.3390/cancers14174235 |
Ejemplares similares
-
The myth of pulmonary metastasectomy
por: Macbeth, Fergus, et al.
Publicado: (2020) -
Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
por: Cardillo, Giuseppe, et al.
Publicado: (2015) -
Pulmonary metastasectomy: limits to credibility
por: Treasure, Tom, et al.
Publicado: (2021) -
The full cohort of 512 patients and the nested controlled trial in 93 patients in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) study raise doubts about the effective size at present claimed
por: Treasure, Tom, et al.
Publicado: (2022) -
Reply to ‘Comment on “The myth of pulmonary metastasectomy’”
por: Macbeth, Fergus, et al.
Publicado: (2020)